Lycia Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Lycia Therapeutics is a small biotechnology company based in South San Francisco, California, focused on addressing disease by degrading extracellular proteins. Its therapies are designed to bind disease-causing extracellular proteins and direct them into cells for lysosomal degradation, with an initial focus on autoimmune and inflammatory diseases. 

It operates within the biotechnology research sector, seeking to fill gaps in targeting proteins that function outside the cell. Its work targets patients with autoimmune and inflammatory conditions, offering a new approach where current options are limited. In February 2025, Lycia appointed Chin Lee as chief medical officer.

Sign up for free to view info

Company overview Employee directory